NHS National Generic Pharmaceuticals Wave 15b
key details
| Value | £742,316,345 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 24 Mar 2025 |
| Procedure | open |
| OCID | ocds-h6vhtk-04e2d4 |
Awards (103)
This procurement was awarded to 103 suppliers. Values shown are per-award; the notice total is £742,316,345.
description
NHS National Pharmaceuticals Generic Products – Wave 15b<br/>Offer reference number: CM/PHG/23/5698<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>CM/PHG/23/5698/01 – Orals (plus non-parenteral) Products<br/>CESW: (Midlands and Southwest): 1st October 2025 to 31st May 2027 (20 months)<br/>NWLN: (Northwest and London North): 1st October 2025 to 31st May 2027 (20 months)<br/>LSNE: (London South and Northeast): 1st October 2025 to 31st May 2027 (20 months)<br/><br/>CM/PHG/23/5698/02 – Hospital Only Products<br/>DCE (Midlands) & DSW (Southwest): 1st October 2025 to 30th September 2027 (24 months)<br/><br/>CM/PHG/23/5698/03 – Hospital Only (Housekeeping) Products<br/>DLS (London South) & DNE (Northeast): 1st October 2025 to 31st May 2026 (8 months)<br/>DNW (Northwest) & DLN (London North): 1st October 2025 to 31st January 2027 (16 months)<br/>DCE (Midlands) & DSW (Southwest): 1st October 2025 to 31st May 2026 (8 months)
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 17 Feb 2025 | Contract notice (F02) | Earlier regulations | 005420-2025 |
| 4 Aug 2025 | Contract award notice (F03) | Earlier regulations | 045712-2025 |
more from NHS England
- Market Engagement Event for East ofEngland prisons · £0 · 11 Sept 2026
- Finance Transformation & Enablement Project Support · £7,944,879 · 10 Sept 2026
- Provision of Public Consultation and Engagement Services for the UISPC · £155,000 · 8 Sept 2026
- Targeted Lung Health Checks National Licences · £1,900,000 · 8 Sept 2026
- Adult Screening and Personalisation Digital Delivery Services · £215,163,316 · 4 Sept 2026
- Step into the NHS - Schools Programme · £65,800 · 2 Sept 2026
- Website hosting and support for hee.nhs.uk and healthcareers.nhs.uk · £168,336 · 1 Sept 2026
- NHS Login Run and Maintain 2 · £30,000,000 · 28 Aug 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.